Pyxis Oncology, Inc. (PYXS) Net income 2020–2025
Pyxis Oncology, Inc. (PYXS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$79.6MFY2025 · since FY2020: -$12.8M → -$79.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.6M | -3.0% |
| FY2024 | -$77.3M | -4.8% |
| FY2023 | -$73.8M | +38.9% |
| FY2022 | -$120.7M | -58.9% |
| FY2021 | -$76.0M | -492.3% |
| FY2020 | -$12.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net marginPYXS Gross profitPYXS Gross marginPYXS Operating incomePYXS Operating marginPYXS Operating cash flowPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →